angiotensin ii has been researched along with piplartine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, J; Geng, S; Li, J; Liu, Y; Lv, W; Wu, X; Zhang, Y | 1 |
| Gu, J; Ji, Y; Lu, Y; Qian, Z; Qiu, M; Sun, W | 1 |
2 other study(ies) available for angiotensin ii and piplartine
| Article | Year |
|---|---|
Piperlongumine inhibits angiotensin II-induced extracellular matrix expression in cardiac fibroblasts.
Topics: Angiotensin II; Animals; Cell Differentiation; Cell Movement; Cell Proliferation; Dioxolanes; Extracellular Matrix; Fibroblasts; Fibrosis; Heart; Humans; Malondialdehyde; MAP Kinase Signaling System; Myofibroblasts; Phosphorylation; Piper; Rats; Reactive Oxygen Species | 2018 |
Piperlongumine attenuates angiotensin-II-induced cardiac hypertrophy and fibrosis by inhibiting Akt-FoxO1 signalling.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiomyopathies; Dioxolanes; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Failure; Kruppel-Like Factor 4; Myocytes, Cardiac; Nerve Tissue Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2021 |